CAMK2G and pulmonary arterial hypertension: There is also a report that Fasudil Dichloroacetate (FDCA) ameliorates hypoxia-induced pulmonary arterial smooth muscle cell (PASMC) dysfunction by inhibiting both CaMK and Rho-kinase signaling pathways, as well as maintaining mitochondrial homeostasis, thus alleviating SU5416 plus hypoxia (SuHx)-induced pulmonary arterial hypertension (PAH) [32].